Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

DR. REDDY'S LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's

BSE5942.65-16.45 (-0.28 %)

PREV CLOSE ( ) 5959.10

OPEN PRICE ( ) 5960.55

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 26331

TODAY'S LOW / HIGH ( )5881.15 5970.00

52 WK LOW / HIGH ( )4383.4 6505.5

NSE5942.85-14.3 (-0.24 %)

PREV CLOSE( ) 5957.15

OPEN PRICE ( ) 6000.00

BID PRICE (QTY) 5942.85 (2)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 342651

TODAY'S LOW / HIGH( ) 5880.80 6000.00

52 WK LOW / HIGH ( )4384.05 6505.9

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 24-02 1984

Management Info

K Satish Reddy - Chairman GV Prasad - Managing Director

Registered Office

Address 8-2-337,Road No. 3,Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040 - 4900 2900

Email mail@drreddys.com / shares@drreddys.com

Website www.drreddys.com

Registrars Details

Bigshare Services Pvt Ltd

306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad

Listing : BSE, NSE, MCX, New York

NEWS

19Apr Dr.Reddy's Laboratories submits certif
Dr.Reddy's Laboratories has submitted Certificate Under Regulation 40(9)..

15Apr Dr. Reddy’s Laboratories’ arm to sell
Dr. Reddy’s Laboratories’ wholly owned subsidiary -- Dr. Reddy’s Laborat..

10Apr Dr. Reddy’s launches drug-free migrain
Dr. Reddy’s Laboratories has launched the drug-free non-invasive migrain..

05Apr Dr. Reddy's, Bayer sign marketing, dis
Dr. Reddy's Laboratories and Bayer have entered into a partnership to ma..

28Mar Dr. Reddy's Laboratories enters into e
Dr. Reddy's Laboratories has entered into an exclusive partnership with..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	4752	26128
Gross Profit	6319	38660
Operating Profit	8839	48061
Net Sales	41030	169625

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bharat Parenterals (BSE) 1455.20 (10.00%)	M.Cap ( in Cr)846.88
Solara Active Pharma (BSE) 551.45 (16.32%)	M.Cap ( in Cr)1985.01
Abbott India (BSE) 26131.85 (0.29%)	M.Cap ( in Cr)55528.36
Windlas Biotech (BSE) 555.05 (6.97%)	M.Cap ( in Cr)1154.42
Concord Biotech (BSE) 1595.25 (1.05%)	M.Cap ( in Cr)16688.90

Shareholding Pattern

	PROMOTERS	26.65%
	NON-INSTITUTION	10.55%
	MUTUAL FUNDS/UTI	7.96%
	FI/BANKS/INSURANCE	7.79%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
ICICI Pru Nifty Pha...	11.49
Nippon India Nifty ...	11.48
ICICI Pru Nifty Hea...	10.07
Axis NIFTY Healthcare ETF	10.06
Aditya Birla SL Nif...	10.05
HDFC Retirement Sav...	8.48
SBI Equity Minimum ...	7.99

Risk Disclosures on Derivatives

Smart Quotes

DR. REDDY'S LABORATORIES LTD.